(4-((2,4-Dimethylphenyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

2-(4-Fluorophenyl)ethyl Chloride>97.0%(GC)1g

6-(2,6-difluorophenyl)-6-oxohexanoic acid, 97.0%, 2g

4-Chlorothiobenzamide, 98.0%, 25g

Iodure de tétrabutylammonium (TBAI), min 99 %, pa, 100 g, emballage plastique.

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-((4-methoxyphenyl)diphenylmethyl)-D-cysteine, 97%, 25g

4-(3-Bromophenyl)dibenzo[b,d]thiophene, 99%, 250mg

4-[(4-bromobenzyl)oxy]benzaldehyde, 250mg

2-Aminoethanethiol p-Toluenesulfonate>98.0%(T)25g

4-Methanesulfonylpiperazin-2-one, 98%, 100mg

1-[3-(4-BROMO-2-METHYL-2H-PYRAZOL-3-YL)-4-METHOXYPHENYL]-3-(2,4-DIFLUOROPHENYL)UREA, 97%, 1g

Methyl 5-chloro-3-(N-methylsulfamoyl)thiophene-2-carboxylate, 95.0%, 25mg

5-Bromo-2-(piperazin-1-yl)pyrimidine, 97.0%, 5g